Brain implant company Neuralink aims to generate $1bn by 2031 following the implantation of its brain-computer interface (BCI) chips in 20,000 people.

Becton, Dickinson and Company (BD) has announced a trial utilising the BD Libertas Wearable Injector for subcutaneous delivery of biologics.

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.

On 20 January 2025, the Trump administration called for a suspension of foreign aid, including global health initiatives such as the US President's Emergency Plan for AIDS Relief (PEPFAR).

Boston Scientific has raised its 2025 profit outlook to between $2.95 and $2.99 per share amid strong Q2 performance in its cardiovascular unit, driven in large part by the uptake of its Farapulse ...

Following a period of relative dormancy, research and development in the Alzheimer’s disease space is booming. And mounting attention, both in the development of disease modifying therapies (DMTs) and ...